Cargando…
Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft
Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is surgery, often followed by radiotherapy. Treatment options for patients with recurrence are limited and, notably, there are no FDA approved therapeutic agents. Development of therapeutic options has been limit...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829812/ https://www.ncbi.nlm.nih.gov/pubmed/24260133 http://dx.doi.org/10.1371/journal.pone.0078895 |